PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14980205-1	2004	Activated protein C (APC), a serine protease with anticoagulant and anti-inflammatory activities, exerts direct cytoprotective effects on endothelium via endothelial protein C receptor-dependent activation of protease activated receptor 1 (PAR1).	Serine	29-35	APC, WNT signaling pathway regulator	Mus musculus	0-19	
14980205-1	2004	Activated protein C (APC), a serine protease with anticoagulant and anti-inflammatory activities, exerts direct cytoprotective effects on endothelium via endothelial protein C receptor-dependent activation of protease activated receptor 1 (PAR1).	Serine	29-35	APC, WNT signaling pathway regulator	Mus musculus	21-24	
14980205-2	2004	Here, we report that APC protects mouse cortical neurons from two divergent inducers of apoptosis, N-methyl-D-aspartate (NMDA) and staurosporine.	N-Methylaspartate	99-119	APC, WNT signaling pathway regulator	Mus musculus	21-24	
14980205-2	2004	Here, we report that APC protects mouse cortical neurons from two divergent inducers of apoptosis, N-methyl-D-aspartate (NMDA) and staurosporine.	N-Methylaspartate	121-125	APC, WNT signaling pathway regulator	Mus musculus	21-24	
14980205-2	2004	Here, we report that APC protects mouse cortical neurons from two divergent inducers of apoptosis, N-methyl-D-aspartate (NMDA) and staurosporine.	Staurosporine	131-144	APC, WNT signaling pathway regulator	Mus musculus	21-24	
14980205-3	2004	APC blocked several steps in NMDA-induced apoptosis downstream to nitric oxide, i.e., caspase-3 activation, nuclear translocation of apoptosis-inducing factor (AIF), and induction of p53, and prevented staurosporine-induced apoptosis by blocking caspase-8 activation upstream of caspase-3 activation and AIF nuclear translocation.	N-Methylaspartate	29-33	APC, WNT signaling pathway regulator	Mus musculus	0-3	
14980205-3	2004	APC blocked several steps in NMDA-induced apoptosis downstream to nitric oxide, i.e., caspase-3 activation, nuclear translocation of apoptosis-inducing factor (AIF), and induction of p53, and prevented staurosporine-induced apoptosis by blocking caspase-8 activation upstream of caspase-3 activation and AIF nuclear translocation.	N-Methylaspartate	29-33	caspase 3	Mus musculus	86-95	
14980205-3	2004	APC blocked several steps in NMDA-induced apoptosis downstream to nitric oxide, i.e., caspase-3 activation, nuclear translocation of apoptosis-inducing factor (AIF), and induction of p53, and prevented staurosporine-induced apoptosis by blocking caspase-8 activation upstream of caspase-3 activation and AIF nuclear translocation.	N-Methylaspartate	29-33	apoptosis-inducing factor, mitochondrion-associated 1	Mus musculus	133-158	
14980205-3	2004	APC blocked several steps in NMDA-induced apoptosis downstream to nitric oxide, i.e., caspase-3 activation, nuclear translocation of apoptosis-inducing factor (AIF), and induction of p53, and prevented staurosporine-induced apoptosis by blocking caspase-8 activation upstream of caspase-3 activation and AIF nuclear translocation.	N-Methylaspartate	29-33	apoptosis-inducing factor, mitochondrion-associated 1	Mus musculus	160-163	
14980205-3	2004	APC blocked several steps in NMDA-induced apoptosis downstream to nitric oxide, i.e., caspase-3 activation, nuclear translocation of apoptosis-inducing factor (AIF), and induction of p53, and prevented staurosporine-induced apoptosis by blocking caspase-8 activation upstream of caspase-3 activation and AIF nuclear translocation.	N-Methylaspartate	29-33	transformation related protein 53, pseudogene	Mus musculus	183-186	
14980205-3	2004	APC blocked several steps in NMDA-induced apoptosis downstream to nitric oxide, i.e., caspase-3 activation, nuclear translocation of apoptosis-inducing factor (AIF), and induction of p53, and prevented staurosporine-induced apoptosis by blocking caspase-8 activation upstream of caspase-3 activation and AIF nuclear translocation.	N-Methylaspartate	29-33	caspase 8	Mus musculus	246-255	
14980205-3	2004	APC blocked several steps in NMDA-induced apoptosis downstream to nitric oxide, i.e., caspase-3 activation, nuclear translocation of apoptosis-inducing factor (AIF), and induction of p53, and prevented staurosporine-induced apoptosis by blocking caspase-8 activation upstream of caspase-3 activation and AIF nuclear translocation.	N-Methylaspartate	29-33	caspase 3	Mus musculus	279-288	
14980205-3	2004	APC blocked several steps in NMDA-induced apoptosis downstream to nitric oxide, i.e., caspase-3 activation, nuclear translocation of apoptosis-inducing factor (AIF), and induction of p53, and prevented staurosporine-induced apoptosis by blocking caspase-8 activation upstream of caspase-3 activation and AIF nuclear translocation.	N-Methylaspartate	29-33	apoptosis-inducing factor, mitochondrion-associated 1	Mus musculus	304-307	
14980205-3	2004	APC blocked several steps in NMDA-induced apoptosis downstream to nitric oxide, i.e., caspase-3 activation, nuclear translocation of apoptosis-inducing factor (AIF), and induction of p53, and prevented staurosporine-induced apoptosis by blocking caspase-8 activation upstream of caspase-3 activation and AIF nuclear translocation.	Nitric Oxide	66-78	APC, WNT signaling pathway regulator	Mus musculus	0-3	
14980205-3	2004	APC blocked several steps in NMDA-induced apoptosis downstream to nitric oxide, i.e., caspase-3 activation, nuclear translocation of apoptosis-inducing factor (AIF), and induction of p53, and prevented staurosporine-induced apoptosis by blocking caspase-8 activation upstream of caspase-3 activation and AIF nuclear translocation.	Staurosporine	202-215	APC, WNT signaling pathway regulator	Mus musculus	0-3